Navigation Links
BioTech Medical LLC Launches Leading Edge 'Powered by SDC' Disinfectant Products
Date:2/12/2009

y season," Ms. Goren added.

Ms. Goren concluded, "BioTech Medical is committed to delivering innovative and environmentally responsible technologies to address significant public health threats. We are thrilled to be able to integrate SpectraSan24 into our business to benefit the global community."

Michael L. Krall, President and CEO of PURE Bioscience, commented, "BioTech Medical has a long and lucrative track record of marketing healthcare products, especially disruptive technologies like SDC. Selling innovative products requires an investment in industry and customer education that then serves as a catalyst to drive the necessary understanding and adoption of a new technology. BioTech Medical's marketing team deploys a structured program to introduce and sell pioneering products, and we believe their strategy will result in near-term market penetration of SpectraSan24 in a variety of industries."

Krall continued, "We are also enthusiastic about BioTech Medical's rapid progress with Cruise Control; a product we continue to believe is particularly well suited to eliminate the threat of dangerous pathogens, including Norovirus, that have become serious problems for many cruise lines and other segments of the transportation and hospitality industries."

SpectraSan24

SpectraSan24, currently undergoing registration in all 50 states, carries a 30-second kill time on standard indicator bacteria, a 24-hour residual kill on standard indicator bacteria, a 2-minute kill time on some resistant strains of bacteria, 10-minute kill time on fungi, 30-second kill time on HIV Type I, and 10-minute kill time on other pathogenic viruses. These claims distinguish the efficacy of SpectraSan24 from many of the leading commercial and consumer products currently on the market, while maintaining lower toxicity ratings. Based on the EPA toxicity ratings from Category I (high toxicity) down to Categ
'/>"/>

SOURCE PURE Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Biotech Finishes on a High in August, Burrill Report Says
3. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
4. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
5. Biotech delists shares from TSXV, continues OTCBB trading
6. Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007
7. MichBio Announces Formation of Biotechnology Legislative Caucus
8. Oncolytics Biotech Inc. announces approval for UK clinical trial
9. Not just humans benefit from animal biotechnology
10. Biotech adds Central American markets to Sucanon distribution
11. GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Many patients with knee osteoarthritis have continued pain ... someone you know) have chronic pain and problems with ... in the ACT-OA clinical trial. , Kevin Darr, ... one of fifteen physicians in the U.S. to receive ... part of a new, multi-site, double blind, placebo-controlled clinical ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 In a new ... Polish mesothelioma patients reported that shoulder pain was their first ... on its website. Click here to read it now. ... analyzed the medical records of 49 mesothelioma patients ... reported that it was shoulder pain that first prompted them ...
(Date:3/6/2015)... Los Angeles cosmetic dentist , Dr. ... whitening. Zoom is a special type of teeth whitening treatment ... teeth whitening treatments, Zoom does its job in about an ... a limited time, Dr. Ghasri is offering Zoom for just ... of $650 and allows patients to try out this revolutionary ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... to be discussed, Ford & Associates Nationwide Legal Services, ... January 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., ... of California. , “In light of a recently ... used Benicar to evaluate and explore the Mayo Clinic's ...
(Date:3/5/2015)... 05, 2015 Shania Twain will be ... a decade. She has hinted that this will be her ... her perform one last time. She has had a residency ... country sweetheart has millions of loyal fans around the world. ... country, Canada, and on June 30th she will be at Madison ...
Breaking Medicine News(10 mins):Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3
... fibrillation study, blood-thinning drug best for those at highest risk ... Older patients, or those with a prior history of stroke, ... to treat atrial fibrillation, a common heart rhythm disorder, a ... researchers also say the drug is especially beneficial for patients ...
... provide research model, possible treatment for type 1 diabetes in ... skin cells from people with type 1 diabetes, researchers were ... changing blood sugar levels, though not as efficiently as normal ... experiment is that scientists now have a preliminary lab model ...
... new report finds , MONDAY, Aug. 31 (HealthDay News) -- ... a pull on medical sleuths nearly 50 years after the ... Navy physician claims that Kennedy suffered from a more complex ... as a young man. , In the Sept. 1 issue ...
... get their care based on how long it takes to ... Center have recently documented a growing trend in the centralization ... which are generally located in metropolitan areas. While trends ... the Journal of Clinical Oncology shows that there ...
... Blue Cross Blue Shield of ... ... new H1N1 (swine) flu puts increased emphasis on preparing early for the upcoming flu season. The ... flu shot as soon as possible. Since both the seasonal flu and the new H1N1 (swine) ...
... , , , ... 31 Healthspottr Media LLC, a new media and publishing ... through innovation today with the launch of the Annual Healthspottr ... award qualified recipients with prizes of up to $250,000 each ...
Cached Medicine News:Health News:Oldest Heart Patients May Get Most From Warfarin 2Health News:Researchers Make Insulin-Producing Cells From Adult Skin Cells 2Health News:Researchers Make Insulin-Producing Cells From Adult Skin Cells 3Health News:JFK's Health Problems More Complex Than Thought 2Health News:JFK's Health Problems More Complex Than Thought 3Health News:Does the distance a patient has to travel affect where they choose to get their care? 2Health News:Flu Season Preparation Comes Early 2Health News:Flu Season Preparation Comes Early 3Health News:Flu Season Preparation Comes Early 4Health News:Healthspottr Launches New Fellows Program for Health Innovators 2Health News:Healthspottr Launches New Fellows Program for Health Innovators 3
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5. März 2015  Die amerikanische Bill ... biopharmazeutische Unternehmen CureVac geben heute bekannt, dass ... US-Dollar) in CureVac investiert. CureVac ist weltweit ... (mRNA). Auf Basis dieses Moleküls entwickelt CureVac ... und zum Schutz vor Infektionskrankheiten. ...
(Date:3/5/2015)... -- CANTEL MEDICAL CORP. (NYSE: CMN ) will ... 2015 on Thursday, March 12 before the market opens, and ... AM ET. To participate in the conference ... the beginning of the call. If you are unable to ... from Thursday, March 12, 2015 through midnight on May 12, ...
Breaking Medicine Technology:BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
...  BioMed Realty Trust, Inc. (NYSE: BMR ) ... with Depomed, Inc. (NASDAQ: DEPO ) at ... a specialty pharmaceutical company, leased approximately 60,000 square feet ... Realty,s multi-tenant Pacific Research Center campus. Commenting ...
... Fla., April 9, 2012 Med-Tek a developer of Healthcare ... physicians, employers and their constituents today announces the launch ... According to the United States Bone ... individuals suffering from musculoskeletal disease ...
Cached Medicine Technology:New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 2New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 3Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP) 2
Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Sol, 80 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: